In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug

  1. Gonzalez-Alvarez, I.
  2. Ruiz-Picazo, A.
  3. Selles-Talavera, R.
  4. Figueroa-Campos, A.
  5. Merino, V.
  6. Bermejo, M.
  7. Gonzalez-Alvarez, M.
Aldizkaria:
Pharmaceutics

ISSN: 1999-4923

Argitalpen urtea: 2024

Alea: 16

Zenbakia: 3

Mota: Artikulua

DOI: 10.3390/PHARMACEUTICS16030390 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus